Loading...
MediciNova, Inc.
4875.T•JPX
Healthcare
Biotechnology
¥206.00
¥-3.00(-1.44%)
MediciNova, Inc. (4875.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for MediciNova, Inc. (4875.T), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-28.03%
↓ 28.03%
Net Income Growth
-28.91%
↓ 28.91%
Operating Cash Flow Growth
-43.22%
↓ 43.22%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-20.77%
↓ 20.77%
ROIC
-25.33%
↓ 25.33%
MediciNova, Inc. (4875.T) Income Statement & Financial Overview
View the income breakdown for MediciNova, Inc. 4875.T across both annual and quarterly reports.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $5370.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | -$5370.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | ||
| R&D Expenses | $1.90M | $1.86M | $1.65M | $1.65M |
| SG&A Expenses | $1.28M | $1.45M | $1.40M | $839326.00 |
| Operating Expenses | $3.18M | $3.31M | $3.05M | $2.49M |
| Total Costs & Expenses | $3.18M | $3.31M | $3.05M | $2.49M |
| Interest Income | $390096.00 | $447847.00 | $435351.00 | $436265.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $5177.00 | $5180.00 | $5370.00 | $5492.00 |
| EBITDA | -$3.18M | -$3.30M | -$3.04M | -$2.48M |
| EBITDA Ratio | $0.00 | |||
| Operating Income | -$3.18M | -$3.31M | -$3.05M | -$2.49M |
| Operating Income Ratio | $0.00 | |||
| Other Income/Expenses (Net) | $374599.00 | $456949.00 | $418296.00 | $434066.00 |
| Income Before Tax | -$2.81M | -$2.85M | -$2.63M | -$2.06M |
| Income Before Tax Ratio | $0.00 | |||
| Income Tax Expense | $5537.00 | $0.00 | $0.00 | -$433218.00 |
| Net Income | -$2.81M | -$2.85B | -$2.63M | -$290.54M |
| Net Income Ratio | $0.00 | |||
| EPS | $0.00 | -$0.06 | -$0.05 | -$5.93 |
| Diluted EPS | $0.00 | -$0.06 | -$0.05 | -$5.93 |
| Weighted Avg Shares Outstanding | $0.00 | $49.05M | $49.05M | $48.99M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $49.05M | $49.05M | $48.99M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan